Glazer Capital LLC’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Glazer Capital LLC’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-965,785	Closed	-$29.1M	–	114
2016 Q2	$29.1M	Buy	+965,785	New	+$19.6M	3.76%	8

Glazer Capital LLC's CPXX Position: Q3 2016 in Review

Glazer Capital LLC sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 965,785 shares — an estimated $29.1M sold.

Glazer Capital LLC first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $29.1M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

Glazer Capital LLC reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Glazer Capital LLC sold 965,785 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $29.1M.
Glazer Capital LLC first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
Glazer Capital LLC's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $29.1M in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Glazer Capital LLC's 13F filing for Q3 2016, filed 14 Nov 2016.